Announcements

RB Press Release - 11/04/11
Acquisition of India’s Paras Pharmaceuticals Completed

Further to the announcement on 13th December 2010, Reckitt Benckiser Group plc (RB) confirms that it has received the necessary regulatory clearances and has completed the acquisition of Paras Pharmaceuticals Limited (Paras).

The acquisition of Paras represents another step forward in RB’s growth strategy in consumer health care. It creates a material health care business in India, one of the most promising health care markets in the world with the addition of a number of strong and leading brands.

- ENDS –

Notes to Editors:

About Reckitt Benckiser Group plc
Reckitt Benckiser (RB) is a world leader in household, health and personal care. It is a FTSE top 25 company, and since 2000 net revenue has more than doubled and the market capitalisation has quadrupled. Today it is the global number 1 or number 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation – typically about one-third of net revenue comes from innovations launched in the prior three years. It has a strong portfolio led by 19 global Powerbrands which are: Finish, Lysol, Dettol, Vanish, Woolite, Durex, Calgon, Airwick, Harpic, Bang, Mortein, Veet, Nurofen, Clearasil, Strepsils, Gaviscon, Mucinex, Scholl and French’s and they account for 69% net revenue.

About Paras Pharmaceuticals Limited
Paras Pharmaceuticals Limited (Paras) is an Indian company with a portfolio of leading Indian over-the-counter Health & Personal Care brands. These include Moov (a topical analgesic pain ointment), D’Cold (a cold and ‘flu remedy), Dermicool (for prickly heat), Krack (a medicated skin treatment for cracked heels) and Itch Guard and Ring Guard anti-fungal creams. Paras also has a personal care business led by Set Wet, a leading hair gel and deodorant brand.

For further information, please contact:

Reckitt Benckiser +44 (0)1753 217800
Joanna Speed Director,
Investor Relations

Andraea Dawson-Shepherd SVP,
Global Corporate Communications and Affairs


Brunswick (Financial PR) +44 (0)20 7404 5959
David Litterick / Teresa Bianchi